Monday, May 25, 2015 4:22:51 AM
RS never do anything for the pps initially.
Now, the PULLBACK IS a buying opportunity.
I do not believe in MANF, because of its competition, not the compound itself, but I am quite sure that ESS is a real product, and the Georgetown test, once proved in 10000 people will also be a real product, If it does not lose out to the published results of what look like better tests.
So buy on the pullback, and only buy for ESS.
Now, someone may spring for the so called spin off, but frankly, if I were them, I would wait, and I would only buy the dx spinoff for the Georgetown test.
The truth is incontrovertible. Malice may attack it, ignorance may deride it, but in the end, there it is.
Winston Churchill
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM